Please login to the form below

Not currently logged in
Email:
Password:

BIO

This page shows the latest BIO news and features for those working in and with pharma, biotech and healthcare.

US, EU regulators start review of Roche’s Soliris rival satralizumab

US, EU regulators start review of Roche’s Soliris rival satralizumab

Meanwhile, another emerging rival in the NMOSD category is  Viela Bio, whose inebilizumab was filed for approval with the FDA earlier this year.

Latest news

More from news
Approximately 20 fully matching, plus 190 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 27 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Infographics